- Home
- AACT vs KURA Comparison
AACT vs KURA Comparison
Compare AACT & KURA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- AACT
- KURA
- Stock Information
- Founded
- AACT 2021
- KURA 2014
- Country
- AACT United States
- KURA United States
- Employees
- AACT N/A
- KURA N/A
- Industry
- AACT
- KURA Biotechnology: Biological Products (No Diagnostic Substances)
- Sector
- AACT
- KURA Health Care
- Exchange
- AACT Nasdaq
- KURA Nasdaq
- Market Cap
- AACT 697.5M
- KURA 700.5M
- IPO Year
- AACT 2023
- KURA N/A
- Fundamental
- Price
- AACT $11.42
- KURA $7.82
- Analyst Decision
- AACT
- KURA Strong Buy
- Analyst Count
- AACT 0
- KURA 13
- Target Price
- AACT N/A
- KURA $24.45
- AVG Volume (30 Days)
- AACT 162.3K
- KURA 2.0M
- Earning Date
- AACT 01-01-0001
- KURA 08-07-2025
- Dividend Yield
- AACT N/A
- KURA N/A
- EPS Growth
- AACT N/A
- KURA N/A
- EPS
- AACT 0.26
- KURA N/A
- Revenue
- AACT N/A
- KURA $83,279,000.00
- Revenue This Year
- AACT N/A
- KURA $60.25
- Revenue Next Year
- AACT N/A
- KURA $155.10
- P/E Ratio
- AACT $43.59
- KURA N/A
- Revenue Growth
- AACT N/A
- KURA N/A
- 52 Week Low
- AACT $10.75
- KURA $5.41
- 52 Week High
- AACT $11.62
- KURA $21.57
- Technical
- Relative Strength Index (RSI)
- AACT 54.66
- KURA 70.70
- Support Level
- AACT $11.30
- KURA $7.47
- Resistance Level
- AACT $11.44
- KURA $8.48
- Average True Range (ATR)
- AACT 0.04
- KURA 0.44
- MACD
- AACT -0.00
- KURA 0.12
- Stochastic Oscillator
- AACT 82.14
- KURA 86.15
About AACT Ares Acquisition Corporation II
Ares Acquisition Corp II is a blank check company.
About KURA Kura Oncology Inc.
Kura Oncology Inc is a clinical-stage biopharmaceutical company committed to realizing the promise of precision medicines for the treatment of cancer. The company's pipeline consists of small molecule drug candidates targeting cancer signaling pathways.